Shares of biotech Scholar Rock more than quadrupled on Monday, adding some $1.9 billion to its market value, after the company said one of its drugs improved motor function in children with a genetic ...
The Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for sepiapterin as a treatment for pediatric and adult patients living with phenylketonuria (PKU).